| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cartesian Therapeutics, Inc. (RNAC) has 13 insiders with recent SEC Form 4 filings, including 3 buys and 13 sells. RNAC is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 8.65M | $73.29M | - | |
| 10% | 511.6K | $4.34M | - | |
| CEO | 323.5K | $2.74M | - | |
| CFO | 121.2K | $1.03M | - | |
| Other | 94.2K | $798.7K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 5, 2023 | Traber Peter G59 | Chief Medical Officer | Sell | 11,644 | $1.13 | $13,185.32 | -0.6% | +12.1% | -46.3% | |
| Jan 5, 2023 | Brunn Carsten86 | President And CEO | Sell | 41,070 | $1.13 | $46,501.22 | -1.3% | +12.1% | -46.3% | |
| Dec 5, 2022 | Brunn Carsten86 | President And CEO | Sell | 4,522 | $1.33 | $6,014.26 | -0.8% | +15.3% | -48.1% | |
| Sep 28, 2022 | Brunn Carsten86 | President And CEO | Sell | 2,692 | $1.66 | $4,470.07 | -0.5% | -43.8% | -34.1% | |
| Sep 2, 2022 | Brunn Carsten86 | President And CEO | Sale+OE | 4,768 | $1.85 | $8,810.31 | -0.9% | -30.1% | -32.8% | |
| Jun 13, 2022 | Cox Carrie Smith51 | Director | Buy | 130,000 | $1.15 | $149,799.00 | +156.9% | +63.4% | +22.3% | |
| May 9, 2022 | Barabe Timothy C49 | Director | Buy | 50,000 | $0.77 | $38,720.00 | +25.0% | +223.0% | +51.9% | |
| Apr 11, 2022 | Springer Timothy A49 | Director, 10% Owner | Buy | 6,681,600 | $0.00 | - | +28.8% | +47.7% | +20.2% | |
| Mar 2, 2022 | Brunn Carsten86 | President And CEO | Sale+OE | 5,443 | $1.81 | $9,863.26 | -1.0% | -51.3% | -12.7% | |
| Jan 5, 2022 | Traber Peter G59 | Chief Medical Officer | Sell | 3,226 | $3.09 | $9,955.11 | -1.3% | -56.3% | -61.6% |